Moneycontrol PRO
Live Now |Traders Carnival 15th Edition - 3 days 12 sessions Virtual Event brought to you by Moneycontrol Pro

Buy Caplin Point Laboratories; target of Rs 1135: ICICI Direct

ICICI Direct is bullish on Caplin Point Laboratories has recommended buy rating on the stock with a target price of Rs 1135 in its research report dated August 07, 2021.

August 10, 2021 / 11:23 AM IST


  • bselive
  • nselive
Todays L/H

ICICI Direct's research report on Caplin Point Laboratories

Caplin derives entire revenues through exports with 92% of revenues from Emerging Markets (LatAm + Africa) where it has an end-to-end business model through last mile logistical solutions for its exclusive distributors. In the US, Caplin has filed 20 ANDAs on its own and with partners with 15 approvals from the USFDA (five with partners) For LatAm markets, it outsources ~40% of products from China, ~20% from Indian vendors and in-house manufacturing of the remaining ~40%


We maintain our BUY rating on the stock due to visible growth in the medium to long term We value Caplin at Rs 1135 i.e. 24x P/E on FY23E EPS

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on are their own, and not that of the website or its management. advises users to check with certified experts before taking any investment decisions.

Broker Research
first published: Aug 10, 2021 11:23 am

stay updated

Get Daily News on your Browser
ISO 27001 - BSI Assurance Mark